Showing results (2441-2450 of 2,734) with videos related to

Sort By:
Pageof 274
Journal for Immunotherapy of Cancer|January 19, 2023
Soluble and cell-based markers of immune checkpoint inhibitor-associated nephritisMeghan E Sise, Qiyu Wang, Harish Seethapathy, et al.
Nature Chemical Biology|May 22, 2019
Small-molecule control of antibody N-glycosylation in engineered mammalian cellsMichelle M Chang, Leonid Gaidukov, Giyoung Jung, et al.
Kidney International|June 11, 2016
Clinicopathological features of acute kidney injury associated with immune checkpoint inhibitorsFrank B Cortazar, Kristen A Marrone, Megan L Troxell, et al.
Military Medicine|December 4, 2014
The Department of Defense Epidemiologic and Economic Burden of Hearing Loss studySharon P Cooper, Hasanat Alamgir, Kristina W Whitworth, et al.
Journal of the American Heart Association|November 26, 2025
Diagnostic and Prognostic Value of High-Sensitivity Troponin T for Cardiovascular Outcomes in Patients Receiving Immune Checkpoint Inhibitor TherapyMilagros Pereyra Pietri, Juan M Farina, Kamal Awad, et al.
Research Square|July 28, 2023
Multi-ancestry epigenome-wide analyses identify methylated sites associated with aortic augmentation index in TOPMed MESAAni Manichaikul, Xiaowei Hu, Jeongok Logan, et al.
Critical Care Medicine|July 18, 2023
Early, Persistent Lymphopenia Is Associated With Prolonged Multiple Organ Failure and Mortality in Septic ChildrenBradley S Podd, Russell K Banks, Ron Reeder, et al.
Scientific Reports|April 1, 2021
CRISPR/Cas9 generated knockout mice lacking phenylalanine hydroxylase protein as a novel preclinical model for human phenylketonuriaKuldeep Singh, Cathleen S Cornell, Robert Jackson, et al.
European Urology Focus|April 7, 2025
Discovery of a Recurrent Frameshift Ashkenazi Jewish Founder Mutation (F722fs) in the PARP Inhibitor-sensitive MMS22L Gene Associated with Higher Risk of Prostate CancerWilliam B Isaacs, Jun Wei, Marta Gielzak, et al.
Medrxiv : the Preprint Server for Health Sciences|November 25, 2022
Acute and Post-Acute COVID-19 Outcomes Among Immunologically Naïve Adults During Delta Versus Omicron WavesMargaret K Doll, Alpana Waghmare, Antje Heit, et al.
Pageof 274